I think I will reserve my judgement on the financial performance until I see the Interim 6 Monthly Financial Report next month. It should give a clearer picture of where the value has been created, particularly in stock on hand. Interesting to note that the the estimated cash outflows for next quarter are approx $1.364m less than for the December quarter.
- Forums
- ASX - By Stock
- AN1
- Ann: Appendix 4C and Notes to Appendix 4C
Ann: Appendix 4C and Notes to Appendix 4C, page-8
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online